Shuttle Pharmaceuticals Holdings (SHPH) Free Cash Flow (2021 - 2026)

Shuttle Pharmaceuticals Holdings' Free Cash Flow history runs 6 years deep, the most recent figure standing at -$2.5 million for Q1 2026.

• On a quarterly basis, Free Cash Flow rose 2.91% year-over-year to -$2.5 million in Q1 2026; TTM through Mar 2026 was -$9.4 million, a 9.2% decrease from a year earlier, with the FY2025 full-year figure at -$12.5 million, down 70.96% from the prior year.
• Free Cash Flow eased to -$2.5 million in Q1 2026 per SHPH's latest filing, from -$973012.0 in the prior quarter.
• Across five years, Free Cash Flow topped out at -$355420.0 in Q2 2022 and bottomed at -$3.4 million in Q2 2025.
• The 5-year median for Free Cash Flow is -$1.4 million (2024), against an average of -$1.6 million.
• Across the five-year window, Free Cash Flow plunged 370.45% in 2022 and surged 63.83% in 2025, its largest moves.
• Year by year, Free Cash Flow stood at -$635824.0 in 2022, then slumped by 67.05% to -$1.1 million in 2023, then sank by 153.27% to -$2.7 million in 2024, then jumped by 63.83% to -$973012.0 in 2025, then tumbled by 152.14% to -$2.5 million in 2026.
• Per Business Quant, the three latest SHPH Free Cash Flow figures stand at -$2.5 million (Q1 2026), -$973012.0 (Q4 2025), and -$2.6 million (Q3 2025).